Skip to main content
Fig. 2 | Annals of Clinical Microbiology and Antimicrobials

Fig. 2

From: In vitro activity of ceftazidime–avibactam and comparators against Gram-negative bacterial isolates collected in the Asia–Pacific region as part of the INFORM program (2015–2017)

Fig. 2

Rates of resistant subsets (ESBL-positive, carbapenemase-negative; carbapenemase-positive, MBL-negative; and carbapenemase-positive, MBL-positive) among Pseudomonas aeruginosa isolates collected in the Asia–Pacific region (INFORM program, 2015–2017). ESBL, extended-spectrum β-lactamase; MBL, metallo-β-lactamase. aCenters in Malaysia collected isolates in 2015 only

Back to article page

Annals of Clinical Microbiology and Antimicrobials

ISSN: 1476-0711

Contact us